Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GHRS
#7030
GH Research PLC Ordinary Shares
14.850
0
-3.51%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-3.51%
Aylık değişim
-9.12%
6 aylık değişim
+4.87%
Yıllık değişim
+4.87%
Önceki kapanış
15.390
0
Open
14.850
0
Bid
Ask
Low
14.850
0
High
14.850
0
Hacim
22
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
GHRS
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
52.03 M
208.1 M
Valuation ratios
Enterprise value
364.2 M
2.36 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Haberler
GH Research hisse fiyat hedefi RBC Capital tarafından 33 dolardan 40 dolara yükseltildi
GH Research stock price target raised to $40 from $33 at RBC Capital
Eli Lilly and Regencell among market cap stock movers on Wednesday
Needham, GH Research hisse fiyat hedefini 19 dolardan 29 dolara yükseltti
GH Research stock price target raised to $29 from $19 at Needham
GH Research hisseleri FDA’nın klinik duraklatmayı kaldırmasıyla yükseldi
GH Research stock jumps as Canaccord raises price target on FDA hold lift
GH Research stock rises as FDA lifts clinical hold on GH001
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug
Tesla, Chevron among market cap stock movers on Monday
TD Cowen, GH Research hissesi için Al notunu yineledi
GH Research stock rating reiterated as Buy by TD Cowen